{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:49:55Z","timestamp":1778708995736,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T00:00:00Z","timestamp":1636934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Health and Medical Research Council of Australia","award":["APP1127981"],"award-info":[{"award-number":["APP1127981"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hand osteoarthritis is a common and disabling problem without effective therapies. Accumulating evidence suggests the role of local inflammation in causing pain and structural progression in hand osteoarthritis, and hand osteoarthritis with synovitis is a commonly encountered clinical phenotype. Methotrexate is a well-established, low-cost, and effective treatment for inflammatory arthritis with a well-described safety profile. The aim of this multicentre, randomised, double-blind, placebo-controlled trial is to determine whether methotrexate reduces pain over 6 months in patients with hand osteoarthritis and synovitis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Ninety-six participants with hand osteoarthritis and synovitis will be recruited through the Osteoarthritis Clinical Trial Network (Melbourne, Hobart, Adelaide, and Perth), and randomly allocated in a 1:1 ratio to receive either methotrexate 20 mg or identical placebo once weekly for 6 months. The primary outcome is pain reduction (assessed by 100 mm visual analogue scale) at 6 months. The secondary outcomes include changes in physical function and quality of life assessed using Functional Index for Hand Osteoarthritis, Australian Canadian Osteoarthritis Hand Index, Health Assessment Questionnaire, Michigan Hand Outcomes Questionnaire, Short-Form-36, tender and swollen joint count, and grip strength, and structural progression assessed using progression of synovitis and bone marrow lesions from magnetic resonance imaging and radiographic progression at 6 months. Adverse events will be recorded. The primary analysis will be by intention to treat, including all participants in their randomised groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>This study will provide high-quality evidence to address whether methotrexate has an effect on reducing pain over 6 months in patients with hand osteoarthritis and synovitis, with major clinical and public health importance. While a positive trial will inform international clinical practice guidelines for the management of hand osteoarthritis, a negative trial would be highly topical and change current trends in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12617000877381. Registered 15 June 2017, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=373124\">https:\/\/www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=373124<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12891-021-04842-0","type":"journal-article","created":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T15:03:04Z","timestamp":1636988584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["METHODS - A randomised controlled trial of METhotrexate to treat Hand Osteoarthritis with Synovitis: study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Yuanyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Teichtahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen I.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita E.","family":"Wluka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Kasza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia M.","family":"Cicuttini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"4842_CR1","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0140-6736(97)07226-7","volume":"350","author":"P Creamer","year":"1997","unstructured":"Creamer P, Hochberg MC. Osteoarthritis. Lancet. 1997;350:503\u20138.","journal-title":"Lancet"},{"key":"4842_CR2","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/ard.2004.023564","volume":"64","author":"S Dahaghin","year":"2005","unstructured":"Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, Pols HA, Hazes JM, Koes BW. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Ann Rheum Dis. 2005;64:682\u20137.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1136\/ard.2011.150078","volume":"70","author":"IK Haugen","year":"2011","unstructured":"Haugen IK, Englund M, Aliabadi P, Niu J, Clancy M, Kvien TK, et al. Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham Osteoarthritis Study. Ann Rheum Dis. 2011;70:1581\u20136.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/PHM.0b013e31802ba28e","volume":"86","author":"CF Dillon","year":"2007","unstructured":"Dillon CF, Hirsch R, Rasch EK, Gu Q. Symptomatic hand osteoarthritis in the United States: prevalence and functional impairment estimates from the third U.S. National Health and Nutrition Examination Survey, 1991-1994. Am J Phys Med Rehabil. 2007;86:12\u201321.","journal-title":"Am J Phys Med Rehabil"},{"key":"4842_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1136\/ard.2010.131151","volume":"70","author":"M Michon","year":"2011","unstructured":"Michon M, Maheu E, Berenbaum F. Assessing health-related quality of life in hand osteoarthritis: a literature review. Ann Rheum Dis. 2011;70:921\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/ard.2007.084772","volume":"68","author":"W Zhang","year":"2009","unstructured":"Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK, Bijlsma JW, et al. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis. 2009;68:8\u201317.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/annrheumdis-2018-213826","volume":"78","author":"M Kloppenburg","year":"2019","unstructured":"Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019;78:16\u201324.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(11)60243-2","volume":"377","author":"JW Bijlsma","year":"2011","unstructured":"Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update with relevance for clinical practice. Lancet. 2011;377:2115\u201326.","journal-title":"Lancet"},{"key":"4842_CR9","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1136\/annrheumdis-2012-201458","volume":"72","author":"MC Kortekaas","year":"2013","unstructured":"Kortekaas MC, Kwok WY, Reijnierse M, Huizinga TW, Kloppenburg M. In erosive hand osteoarthritis more inflammatory signs on ultrasound are found than in the rest of hand osteoarthritis. Ann Rheum Dis. 2013;72:930\u20134.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.berh.2009.12.007","volume":"24","author":"L Punzi","year":"2010","unstructured":"Punzi L, Frigato M, Frallonardo P, Ramonda R. Inflammatory osteoarthritis of the hand. Best Pract Res Clin Rheumatol. 2010;24:301\u201312.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4842_CR11","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2013-205003","volume":"74","author":"MC Kortekaas","year":"2015","unstructured":"Kortekaas MC, Kwok WY, Reijnierse M, Kloppenburg M. Inflammatory ultrasound features show independent associations with progression of structural damage after over 2 years of follow-up in patients with hand osteoarthritis. Ann Rheum Dis. 2015;74:1720\u20134.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR12","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/art.39438","volume":"68","author":"MC Kortekaas","year":"2016","unstructured":"Kortekaas MC, Kwok WY, Reijnierse M, Stijnen T, Kloppenburg M. Brief report: association of inflammation with development of erosions in patients with hand osteoarthritis: a prospective ultrasonography study. Arthritis Rheumatol. 2016;68:392\u20137.","journal-title":"Arthritis Rheumatol"},{"key":"4842_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/annrheumdis-2014-205949","volume":"75","author":"IK Haugen","year":"2016","unstructured":"Haugen IK, Slatkowsky-Christensen B, Boyesen P, Sesseng S, van der Heijde D, Kvien TK. MRI findings predict radiographic progression and development of erosions in hand osteoarthritis. Ann Rheum Dis. 2016;75:117\u201323.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR14","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/annrheumdis-2015-207241","volume":"75","author":"A Mathiessen","year":"2016","unstructured":"Mathiessen A, Slatkowsky-Christensen B, Kvien TK, Hammer HB, Haugen IK. Ultrasound-detected inflammation predicts radiographic progression in hand osteoarthritis after 5 years. Ann Rheum Dis. 2016;75:825\u201330.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR15","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/art.24312","volume":"59","author":"HI Keen","year":"2008","unstructured":"Keen HI, Wakefield RJ, Grainger AJ, Hensor EM, Emery P, Conaghan PG. An ultrasonographic study of osteoarthritis of the hand: synovitis and its relationship to structural pathology and symptoms. Arthritis Rheum. 2008;59:1756\u201363.","journal-title":"Arthritis Rheum"},{"key":"4842_CR16","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/ard.2009.124875","volume":"69","author":"MC Kortekaas","year":"2010","unstructured":"Kortekaas MC, Kwok WY, Reijnierse M, Watt I, Huizinga TW, Kloppenburg M. Pain in hand osteoarthritis is associated with inflammation: the value of ultrasound. Ann Rheum Dis. 2010;69:1367\u20139.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1136\/ard.2010.128504","volume":"69","author":"R Wittoek","year":"2010","unstructured":"Wittoek R, Carron P, Verbruggen G. Structural and inflammatory sonographic findings in erosive and non-erosive osteoarthritis of the interphalangeal finger joints. Ann Rheum Dis. 2010;69:2173\u20136.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1136\/annrheumdis-2011-200341","volume":"71","author":"IK Haugen","year":"2012","unstructured":"Haugen IK, Boyesen P, Slatkowsky-Christensen B, Sesseng S, van der Heijde D, Kvien TK. Associations between MRI-defined synovitis, bone marrow lesions and structural features and measures of pain and physical function in hand osteoarthritis. Ann Rheum Dis. 2012;71:899\u2013904.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR19","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1136\/annrheumdis-2014-205348","volume":"74","author":"X Chevalier","year":"2015","unstructured":"Chevalier X, Ravaud P, Maheu E, Baron G, Rialland A, Vergnaud P, et al. Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial. Ann Rheum Dis. 2015;74:1697\u2013705.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1136\/annrheumdis-2018-213202","volume":"77","author":"M Kloppenburg","year":"2018","unstructured":"Kloppenburg M, Ramonda R, Bobacz K, Kwok WY, Elewaut D, Huizinga TWJ, et al. Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018;77:1757\u201364.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR21","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/ard.2011.149849","volume":"71","author":"G Verbruggen","year":"2012","unstructured":"Verbruggen G, Wittoek R, Vander Cruyssen B, Elewaut D. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis. 2012;71:891\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0049-0172(05)80009-5","volume":"22","author":"LR Belhorn","year":"1993","unstructured":"Belhorn LR, Hess EV. Erosive osteoarthritis. Semin Arthritis Rheum. 1993;22:298\u2013306.","journal-title":"Semin Arthritis Rheum"},{"key":"4842_CR23","first-page":"Cd000957","volume":"2014","author":"MA Lopez-Olivo","year":"2014","unstructured":"Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME. Methotrexate for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2014;2014:Cd000957.","journal-title":"Cochrane Database Syst Rev"},{"key":"4842_CR24","doi-asserted-by":"publisher","first-page":"e89990","DOI":"10.5812\/aapm.89990","volume":"9","author":"A Enteshari-Moghaddam","year":"2019","unstructured":"Enteshari-Moghaddam A, Isazadehfar K, Habibzadeh A, Hemmati M. Efficacy of Methotrexate on Pain Severity Reduction and Improvement of Quality of Life in Patients with Moderate to Severe Knee Osteoarthritis. Anesth Pain Med. 2019;9:e89990.","journal-title":"Anesth Pain Med"},{"key":"4842_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/rheumatology\/kes386","volume":"52","author":"CY Wenham","year":"2013","unstructured":"Wenham CY, Grainger AJ, Hensor EM, Caperon AR, Ash ZR, Conaghan PG. Methotrexate for pain relief in knee osteoarthritis: an open-label study. Rheumatology. 2013;52:888\u201392.","journal-title":"Rheumatology"},{"key":"4842_CR26","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.semarthrit.2021.04.016","volume":"51","author":"S Ferrero","year":"2021","unstructured":"Ferrero S, Wittoek R, Allado E, Cruzel C, Fontas E, Breuil V, et al. Methotrexate treatment in hand osteoarthritis refractory to usual treatments: a randomised, double-blind, placebo-controlled trial. Semin Arthritis Rheum. 2021;51:831\u20138.","journal-title":"Semin Arthritis Rheum"},{"key":"4842_CR27","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.","journal-title":"BMJ"},{"key":"4842_CR28","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.joca.2015.03.007","volume":"23","author":"M Kloppenburg","year":"2015","unstructured":"Kloppenburg M, Maheu E, Kraus VB, Cicuttini F, Doherty M, Dreiser RL, et al. OARSI clinical trials recommendations: design and conduct of clinical trials for hand osteoarthritis. Osteoarthritis Cartilage. 2015;23:772\u201386.","journal-title":"Osteoarthritis Cartilage"},{"key":"4842_CR29","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3899\/jrheum.131086","volume":"41","author":"IK Haugen","year":"2014","unstructured":"Haugen IK, \u00d8stergaard M, Eshed I, McQueen FM, Bird P, Gandjbakhch F, et al. Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system. J Rheumatol. 2014;41:386\u201391.","journal-title":"J Rheumatol"},{"key":"4842_CR30","first-page":"481","volume":"33","author":"M Hoekstra","year":"2006","unstructured":"Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis. J Rheumatol. 2006;33:481\u20135.","journal-title":"J Rheumatol"},{"key":"4842_CR31","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3899\/jrheum.130738","volume":"41","author":"B Shea","year":"2014","unstructured":"Shea B, Swinden MV, Ghogomu ET, Ortiz Z, Katchamart W, Rader T, et al. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis. J Rheumatol. 2014;41:1049\u201360.","journal-title":"J Rheumatol"},{"key":"4842_CR32","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3899\/jrheum.141228","volume":"42","author":"AW Visser","year":"2015","unstructured":"Visser AW, Boyesen P, Haugen IK, Schoones JW, van der Heijde DM, Rosendaal FR, et al. Instruments measuring pain, physical function, or patient\u2019s global assessment in hand osteoarthritis: a systematic literature search. J Rheumatol. 2015;42:2118\u201334.","journal-title":"J Rheumatol"},{"key":"4842_CR33","first-page":"43s","volume":"62","author":"RL Dreiser","year":"1995","unstructured":"Dreiser RL, Maheu E, Guillou GB, Caspard H, Grouin JM. Validation of an algofunctional index for osteoarthritis of the hand. Rev Rhum Engl Ed. 1995;62:43s\u201353s.","journal-title":"Rev Rhum Engl Ed"},{"key":"4842_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1053\/joca.2002.0838","volume":"10","author":"N Bellamy","year":"2002","unstructured":"Bellamy N, Campbell J, Haraoui B, Gerecz-Simon E, Buchbinder R, Hobby K, et al. Clinimetric properties of the AUSCAN Osteoarthritis Hand Index: an evaluation of reliability, validity and responsiveness. Osteoarthritis Cartilage. 2002;10:863\u20139.","journal-title":"Osteoarthritis Cartilage"},{"key":"4842_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137\u201345.","journal-title":"Arthritis Rheum"},{"key":"4842_CR36","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0363-5023(98)80042-7","volume":"23","author":"KC Chung","year":"1998","unstructured":"Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J Hand Surg Am. 1998;23:575\u201387.","journal-title":"J Hand Surg Am"},{"key":"4842_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473\u201383.","journal-title":"Med Care"},{"key":"4842_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/ard.40.1.75","volume":"40","author":"DV Doyle","year":"1981","unstructured":"Doyle DV, Dieppe PA, Scott J, Huskisson EC. An articular index for the assessment of osteoarthritis. Ann Rheum Dis. 1981;40:75\u20138.","journal-title":"Ann Rheum Dis"},{"key":"4842_CR39","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.joca.2015.03.003","volume":"23","author":"DJ Hunter","year":"2015","unstructured":"Hunter DJ, Arden N, Cicuttini F, Crema MD, Dardzinski B, Duryea J, et al. OARSI Clinical Trials Recommendations: Hand imaging in clinical trials in osteoarthritis. Osteoarthritis Cartilage. 2015;23:732\u201346.","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"4842_CR40","doi-asserted-by":"publisher","first-page":"A1","DOI":"10.1016\/j.joca.2006.11.009","volume":"15","author":"RD Altman","year":"2007","unstructured":"Altman RD, Gold GE. Atlas of individual radiographic features in osteoarthritis, revised. Osteoarthritis Cartilage. 2007;15(Suppl A):A1\u201356.","journal-title":"Osteoarthritis Cartilage"},{"key":"4842_CR41","first-page":"1221","volume":"23","author":"FM Cicuttini","year":"1996","unstructured":"Cicuttini FM, Baker JR, Spector TD. The association of obesity with osteoarthritis of the hand and knee in women: a twin study. J Rheumatol. 1996;23:1221\u20136.","journal-title":"J Rheumatol"},{"key":"4842_CR42","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.joca.2014.05.026","volume":"22","author":"AW Visser","year":"2014","unstructured":"Visser AW, B\u00f8yesen P, Haugen IK, Schoones JW, van der Heijde DM, Rosendaal FR, et al. Radiographic scoring methods in hand osteoarthritis--a systematic literature search and descriptive review. Osteoarthritis Cartilage. 2014;22:1710\u201323.","journal-title":"Osteoarthritis Cartilage"},{"key":"4842_CR43","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(19)32489-4","volume":"394","author":"FPB Kroon","year":"2019","unstructured":"Kroon FPB, Kortekaas MC, Boonen A, Bohringer S, Reijnierse M, Rosendaal FR, et al. Results of a 6-week treatment with 10 mg prednisolone in patients with hand osteoarthritis (HOPE): a double-blind, randomised, placebo-controlled trial. Lancet. 2019;394:1993\u20132001.","journal-title":"Lancet"},{"key":"4842_CR44","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1002\/acr.21747","volume":"64","author":"F Tubach","year":"2012","unstructured":"Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res. 2012;64:1699\u2013707.","journal-title":"Arthritis Care Res"},{"key":"4842_CR45","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0962280208097243","volume":"20","author":"M Maracy","year":"2011","unstructured":"Maracy M, Dunn G. Estimating dose-response effects in psychological treatment trials: the role of instrumental variables. Stat Methods Med Res. 2011;20:191\u2013215.","journal-title":"Stat Methods Med Res"},{"key":"4842_CR46","first-page":"1800","volume":"28","author":"F Nakazawa","year":"2001","unstructured":"Nakazawa F, Matsuno H, Yudoh K, Katayama R, Sawai T, Uzuki M, et al. Methotrexate inhibits rheumatoid synovitis by inducing apoptosis. J Rheumatol. 2001;28:1800\u20138.","journal-title":"J Rheumatol"},{"key":"4842_CR47","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1517\/14712598.1.5.817","volume":"1","author":"MB Goldring","year":"2001","unstructured":"Goldring MB. Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther. 2001;1:817\u201329.","journal-title":"Expert Opin Biol Ther"},{"key":"4842_CR48","first-page":"365","volume":"24","author":"MD Smith","year":"1997","unstructured":"Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol. 1997;24:365\u201371.","journal-title":"J Rheumatol"},{"key":"4842_CR49","first-page":"1662","volume":"17","author":"SL Myers","year":"1990","unstructured":"Myers SL, Brandt KD, Ehlich JW, Braunstein EM, Shelbourne KD, Heck DA, et al. Synovial inflammation in patients with early osteoarthritis of the knee. J Rheumatol. 1990;17:1662\u20139.","journal-title":"J Rheumatol"},{"key":"4842_CR50","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/rheumatology\/keh512","volume":"44","author":"AJ Kinder","year":"2005","unstructured":"Kinder AJ, Hassell AB, Brand J, Brownfield A, Grove M, Shadforth MF. The treatment of inflammatory arthritis with methotrexate in clinical practice: treatment duration and incidence of adverse drug reactions. Rheumatology (Oxford). 2005;44:61\u20136.","journal-title":"Rheumatology (Oxford)"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-021-04842-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-021-04842-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T23:06:43Z","timestamp":1675897603000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-021-04842-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["4842"],"URL":"https:\/\/doi.org\/10.1186\/s12891-021-04842-0","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval has been obtained from Alfred Hospital Ethics Committee (290\/17), Monash University Human Research Ethics Committee (10725), University of Tasmania Human Research Ethics Committee (H0016794), Central Adelaide Local Health Network Human Research Ethics Committee (HREC\/18\/CALHN\/458), and South Metropolitan Health Service Human Research Ethics Committee (RGS0000000573). Participants will only be included after they have provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"GJ received honoraria for talks from BMS, Roche, AbbVie, Amgen, Lilly, Novartis, and Janssen, and grant for a clinical trial from Covance. The other authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"953"}}